Comparison of anti-Vi IgG responses between two clinical studies of typhoid Vi conjugate vaccines (Vi-DT vs Vi-TT).
Salmonella enterica serovar Typhi (S. Typhi) is a causative agent for typhoid fever and especially critical in developing countries. Although clinical studies for various typhoid conjugate vaccines (TCVs) have been performed, there are no comparative data on the immune responses of vaccines due to l...
Main Authors: | Eun Young Lee, Ju Yeon Park, Deok Ryun Kim, Manki Song, Sushant Sahastrabuddhe, Hun Kim, Yun Chon, Jae Seung Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-03-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0008171 |
Similar Items
-
Anti-S. typhi Vi IgG levels in children with and without typhoid vaccinations
by: Sriandayani Sriandayani, et al.
Published: (2014-10-01) -
Novel Vi conjugate vaccines against typhoid
by: Arcuri, Melissa
Published: (2017) -
ViTT: Vision Transformer Tracker
by: Xiaoning Zhu, et al.
Published: (2021-08-01) -
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study
by: Maria Rosario Capeding, et al.
Published: (2020-10-01) -
25 years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal.
by: Deepak Bajracharya, et al.
Published: (2014-01-01)